冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro inhibitors.pdf

冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro inhibitors.pdf

ID:50678532

大?。?.36 MB

頁數(shù):35頁

時間:2020-03-16

冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro  inhibitors.pdf_第1頁
冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro  inhibitors.pdf_第2頁
冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro  inhibitors.pdf_第3頁
冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro  inhibitors.pdf_第4頁
冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro  inhibitors.pdf_第5頁
資源描述:

《冠狀病毒Coronavirusl論文-2017 Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Pro inhibitors.pdf》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。

1、AcceptedManuscriptIdentificationandevaluationofpotentMiddleEastrespiratorysyndromecoronavirusPro(MERS-CoV)3CLinhibitorsVathanKumar,JinSooShin,Jiun-JieShie,KeunBonKu,ChonsaengKim,YunYoungGo,Kai-FaHuang,MeehyeinKim,Po-HuangLiangPII:S0166-3542(16)30508-3DOI:10.10

2、16/j.antiviral.2017.02.007Reference:AVR4009Toappearin:AntiviralResearchReceivedDate:13September2016RevisedDate:10February2017AcceptedDate:14February2017Pleasecitethisarticleas:Kumar,V.,Shin,J.S.,Shie,J.-J.,Ku,K.B.,Kim,C.,Go,Y.Y.,Huang,K.-F.,Kim,M.,Liang,P.-H.,

3、IdentificationandevaluationofpotentMiddleEastrespiratoryProsyndromecoronavirus(MERS-CoV)3CLinhibitors,AntiviralResearch(2017),doi:10.1016/j.antiviral.2017.02.007.ThisisaPDFfileofanuneditedmanuscriptthathasbeenacceptedforpublication.Asaservicetoourcustomerswear

4、eprovidingthisearlyversionofthemanuscript.Themanuscriptwillundergocopyediting,typesetting,andreviewoftheresultingproofbeforeitispublishedinitsfinalform.Pleasenotethatduringtheproductionprocesserrorsmaybediscoveredwhichcouldaffectthecontent,andalllegaldisclaime

5、rsthatapplytothejournalpertain.ACCEPTEDMANUSCRIPTMANUSCRIPTACCEPTEDACCEPTEDMANUSCRIPTIdentificationandevaluationofpotentMiddleEastrespiratorysyndromecoronavirus(MERS-CoV)Pro3CLinhibitorsa,1b,1cbbbVathanKumar,JinSooShin,Jiun-JieShie,KeunBonKu,ChonsaengKim,YunYo

6、ungGo,ab,*a,d,*Kai-FaHuang,MeehyeinKim,Po-HuangLiangaInstituteofBiologicalChemistry,AcademiaSinica,Taipei,TaiwanbKoreaResearchInstituteofChemicalTechnology,Daejeon,RepublicofKoreacInstituteofChemistry,AcademiaSinica,Taipei,TaiwandInstituteofBiochemicalSciences

7、,NationalTaiwanUniversity,Taipei,Taiwan1Theseauthorscontributedequallytothiswork.MANUSCRIPT*CorrespondingauthorName:MeehyeinKim,Ph.D.Address:CenterforVirusResearchandTesting,KoreaResearchInstituteofChemicalTechnology,141Gajeongro,Yuseong,Daejeon34114,Republico

8、fKoreACCEPTEDaE-mail:mkim@krict.re.krTelephone:+82-42-860-75401ACCEPTEDMANUSCRIPTFax:+82-42-860-7400Name:Po-HuangLiang,Ph.D.Address:InstituteofBiologicalChemistry,AcademiaSinica,Ta

當前文檔最多預(yù)覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當前文檔最多預(yù)覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動畫的文件,查看預(yù)覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負責(zé)整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細閱讀文檔內(nèi)容,確認文檔內(nèi)容符合您的需求后進行下載,若出現(xiàn)內(nèi)容與標題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費完成后未能成功下載的用戶請聯(lián)系客服處理。